Literature DB >> 12570810

PACAP in avians: origin, occurrence, and receptors--pharmacological and functional considerations.

Jerzy Z Nowak1, Jolanta B Zawilska.   

Abstract

Pituitary adenylate cyclase-activating polypeptide (PACAP) is a novel member of the secretin/glucagon/vasoactive intestinal peptide (VIP) superfamily. In vertebrates, including avians, it occurs in two forms: PACAP(38) and PACAP(27). PACAP structure is well conserved during evolution, being identical in mammals, and showing one amino acid dfifference in avians (chick, turkey). PACAP is widely distributed in the central nervous system and peripheral tissues and displays a pleiotropic activity, including functions as a hypophysiotropic hormone, neuromodulator, and neurotrophic factor. PACAP exerts its biological actions through three types of receptors designated PAC(1), VPAC(1) and VPAC(1). This review (1) presents the current knowledge on PACAP origin, distribution and function, (2) compares the avian findings with those found in mammals, and (3) describes receptor-linked mechanisms in avians, including recent data on receptor-related signal transduction pathways, with a special emphasis on receptor pharmacology and function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12570810     DOI: 10.2174/1381612033391586

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  12 in total

1.  Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.

Authors:  Jolanta B Zawilska; Agnieszka Dejda; Pawel Niewiadomski; Illana Gozes; Jerzy Z Nowak
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

2.  Duck pancreatic acinar cell as a unique model for independent cholinergic stimulation-secretion coupling.

Authors:  Bi Jue Wang; Hui Yuan Liang; Zong Jie Cui
Journal:  Cell Mol Neurobiol       Date:  2009-04-16       Impact factor: 5.046

3.  Effects of PACAP and VIP on cAMP-generating system and proliferation of C6 glioma cells.

Authors:  Paulina Sokolowska; Jerzy Z Nowak
Journal:  J Mol Neurosci       Date:  2008-05-20       Impact factor: 3.444

4.  Antagonism of VIP-stimulated cyclic AMP formation in chick brain.

Authors:  Jerzy Z Nowak; Paulina Sedkowska; Jolanta B Zawilska; Illana Gozes; Douglas E Brenneman
Journal:  J Mol Neurosci       Date:  2003-04       Impact factor: 3.444

5.  Identification of a gene associated with avian migratory behaviour.

Authors:  Jakob C Mueller; Francisco Pulido; Bart Kempenaers
Journal:  Proc Biol Sci       Date:  2011-02-16       Impact factor: 5.349

6.  Interactions between a Candidate Gene for Migration (ADCYAP1), Morphology and Sex Predict Spring Arrival in Blackcap Populations.

Authors:  Raeann Mettler; Gernot Segelbacher; H Martin Schaefer
Journal:  PLoS One       Date:  2015-12-18       Impact factor: 3.240

Review 7.  PACAP and its role in primary headaches.

Authors:  Lars Edvinsson; János Tajti; Levente Szalárdy; László Vécsei
Journal:  J Headache Pain       Date:  2018-03-09       Impact factor: 7.277

8.  Variation in candidate genes CLOCK and ADCYAP1 does not consistently predict differences in migratory behavior in the songbird genus Junco.

Authors:  Mark P Peterson; Mikus Abolins-Abols; Jonathan W Atwell; Rebecca J Rice; Borja Milá; Ellen D Ketterson
Journal:  F1000Res       Date:  2013-04-22

9.  Adcyap1 polymorphism covaries with breeding latitude in a Nearctic migratory songbird, the Wilson's warbler (Cardellina pusilla).

Authors:  Gaia Bazzi; Andrea Galimberti; Quentin R Hays; Ilaria Bruni; Jacopo G Cecere; Luca Gianfranceschi; Keith A Hobson; Yolanda E Morbey; Nicola Saino; Christopher G Guglielmo; Diego Rubolini
Journal:  Ecol Evol       Date:  2016-04-07       Impact factor: 2.912

Review 10.  Current State of Understanding of the Role of PACAP in the Hypothalamo-Hypophyseal Gonadotropin Functions of Mammals.

Authors:  Katalin Köves; Enikő Szabó; Orsolya Kántor; Andrea Heinzlmann; Flóra Szabó; Ágnes Csáki
Journal:  Front Endocrinol (Lausanne)       Date:  2020-03-06       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.